Needle-Free Methods of Drug Delivery

Joseph Priestley Society
Thursday, February 23, 2023
1:00 p.m.–2:00 p.m. EST (UTC -5)

Our February Joseph Priestley Society program features keynote speaker Alina Rui Su, founder and CEO of NovaXS Biotech, a startup focused on advanced needle-free drug delivery and the long-term health of patients.

She will discuss her work transforming medicine delivery into more accessible, proactive, and personalized solutions for chronic diseases. These topics and others will be addressed through a lively discussion moderated by JPS chair Maria L. Maccecchini, founder, president, and CEO of Annovis Bio.

About the Speaker

Alina Su, CEO and founder of NovaXS, is passionate about creating technology that makes healthcare equitable and accessible to all. An entrepreneur and inventor, she holds six medical device patents in China and the United States, with three more patent applications pending. Su is a PhD student in biological and biomedical science at Harvard Medical School.


Alina Rui Su with cathedral in background

Courtesy of Alina Rui Su

Alina is an Asia-Pacific and Korea representative in innovation of biotechnology for the Economist Intelligence Unit; an advisor to the Biotech Translational Platform, which assists with the commercialization of multiple technologies; a Lawrence Berkeley National Laboratory and QB3 researcher in bioengineering regenerative medicine; and a U8 World Entrepreneurship and Innovation Summit leader.

About the Series

The Joseph Priestley Society (JPS) promotes a deeper understanding of science, technology, and industry, with an emphasis on innovation and entrepreneurship. Speakers are leaders from a wide variety of large and small chemical companies and the financial, consulting, and academic communities.

For more information about this event, please contact